Ki Summary BindingDB logo
myBDB logout
Reaction Details
Report a problem with these data
TargetMalignant T-cell-amplified sequence 1
LigandBDBM403142
Substrate/Competitorn/a
Meas. Tech.MTT assay
EC50<20.0±n/a nM
Citation Bannister, TDRoush, WRChoi, JYNair, RTsai, ASMishra, JKCleveland, JL Heterocyclic inhibitors of monocarboxylate transporter US Patent US10329303 Publication Date 6/25/2019
More Info.:Get all data from this article,  Assay Method
 
Malignant T-cell-amplified sequence 1
Name:Malignant T-cell-amplified sequence 1
Synonyms:MCT-1 | MCT1 | MCTS1 | MCTS1_HUMAN | Multiple copies T-cell malignancies
Type:Enzyme Catalytic Domain
Mol. Mass.:20563.62
Organism:Homo sapiens (human)
Description:n/a
Residue:181
Sequence:
MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIE
ILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPG
AKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTY
K
Blast this sequence in BindingDB or PDB
  Blast E-value cutoff:
BDBM403142
n/a
NameBDBM403142
Synonyms:US10329303, Example 15
TypeSmall organic molecule
Emp. Form.C24H28N4O3S
Mol. Mass.452.569
SMILESCC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3cccc(CO)c3)c2c(=O)n(C)c1=O
Structure
Search PDB for entries with ligand similarity:Similarity to this molecule at least: